REG - Tristel PLC - Appointment of Chief Financial Officer

TristelAnnouncement

Thu 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250717:nRSQ3648Ra&default-theme=true

RNS Number : 3648R  Tristel PLC  17 July 2025

TRISTEL plc

("Tristel" or the "Company")

 

Appointment of Chief Financial Officer

 

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products,
announces the appointment of Anna Wasyl as Chief Financial Officer ("CFO"),
with effect from 1 September 2025. Anna's appointment follows the conclusion
of a competitive selection process and replaces Liz Dixon, who left the
business on 30 June 2025, having been with the Group since 2007.

 

Anna is a dynamic and commercially focused CFO with a strong track record in
multinational organisations and technology-driven sectors, including medical
devices, robotics, and industrial automation. She brings a rare blend of
operational, strategic, and financial expertise, with over 20 years of
experience across publicly listed and venture-backed companies. Throughout her
career, Anna has led cross functional high-performing teams, overseen business
operations with revenues up to $1 billion, and raised over $200 million in
capital.

 

Anna joins Tristel from CMR Surgical ("CMR"), the Cambridge-based global
surgical robotics business, where she served as Chief Commercial Partnerships
and Operations Officer, having previously held the role of Group CFO. During
her tenure, Anna led the company through go-to-market model transition and a
major turnaround programme, delivering significant reduction of operational
expenses and cash burn. She was also instrumental in introducing innovative
commercial models, new revenue streams, and launching strategic partnerships
across 20 countries.

 

Prior to joining CMR, Anna spent 18 years at ABB Group ("ABB"), a global
leader in automation and robotics, where she rose through the ranks to become
CFO of the Robotics & Discrete Automation Business Unit in Shanghai,
China. Her earlier international postings with ABB included the USA, Mexico,
and Switzerland, giving her deep cross-cultural and functional insight.

 

Anna holds a Master's degree in International Economic Relations from the
Warsaw School of Economics and has completed executive programmes at Wharton
Business School, Duke University, and IMD Lausanne. She is fluent in English,
Spanish, and Polish. She lives in Cambridge, UK.

 

 

Anna Wasyl, Chief Financial Officer of Tristel plc

 

Anna Wasyl, incoming CFO of Tristel, commented: "I am honoured to join
Tristel as its new Chief Financial Officer. Tristel has established a
well-earned reputation for innovation and leadership in infection prevention,
and I look forward to being CFO for this exceptional business. I am eager to
build on the strong financial and strategic foundation established by Liz
Dixon, and to working closely with the Board, executive leadership, and global
teams to drive long-term, sustainable growth. My priorities will include
capitalising on global market opportunities, enhancing operational efficiency,
and strengthening our presence in key geographies. Together, we will continue
to focus on delivering growth and exceptional value to our customers and
stakeholders."

Matt Sassone, CEO of Tristel, commented: "Anna's appointment comes at an
exciting and important time for Tristel. Her broad international background,
commercial mindset, and hands-on approach to both strategy and execution are
exactly what we need as we enter our next phase of growth. I have been
impressed by her achievements in both large corporates and scale-up
environments and am confident she will make a significant contribution to our
Board and to the business."

 

Bruno Holthof, Chair of Tristel, commented: "We are very pleased Anna is
joining as our new CFO. She brings a strong track record of driving
sustainable growth and scaling up operations whilst also realising substantial
savings. Anna will be supported by a committed senior management team that has
built Tristel over its 20 years as a public company. The Board is confident
that fusing the energy of new leadership with the organisation's remarkable
domain knowledge of the infection prevention market will secure Tristel's
continuing success."

 

Additional Information on the Board Appointment

The following additional information is provided with regards to the
appointment of Anna Katarzyna Wasyl, aged 45, in accordance with AIM Rule 17
and Schedule 2(g) of the AIM Rules for Companies:

 

 Current Directorships/partnerships  Directorships/partnerships within the last five years:
 CMR Surgical Device Co Ltd          None

 

Anna does not hold any shares or options in the Company.

 

There are no further disclosures required under Rule 17 and Schedule 2(g) of
the AIM Rules for Companies.

 

For further information please contact:

 Tristel plc                                                                   Via Walbrook PR
 Matt Sassone, Chief Executive Officer                                         www.investors.tristel.com (http://www.investors.tristel.com/)

 Walbrook PR Ltd                                                               Tel: 020 7933 8780 or tristel@walbrookpr.com
 Paul McManus / Lianne Applegarth / Alice Woodings    Mob: 07980 541 893/ 07584 391 303/ 07407 804 654

 Cavendish Capital Markets Ltd                                                 Tel: 020 7220 0500
 Geoff Nash / Callum Davidson/Trisyia Jamaludin (Corporate Finance)
 Sunila de Silva (Corporate Broking) / Louise Talbot (Sales)

 

 

About Tristel plc

Tristel plc is a global infection prevention company focussed on the
manufacture and supply of products using its unique proprietary chlorine
dioxide (ClO(2)) chemistry. The Company is a market leader in manual
decontamination of medical devices, supplying hospitals under the Tristel
(https://tristel.com/) brand, and under the Cache
(https://thecachecollection.com/) brand provides products for sporicidal
surface disinfection, a more sustainable alternative to commonly used
pre-wetted plastic wipes.

 

Tristel's head office and manufacturing facility is located in Snailwell, near
Cambridge, and operates globally employing approximately 270 people across 16
subsidiaries selling into 40+ countries. The Company targets annual revenue
growth of between 10% and 15% and an EBITDA margin of at least 25% and the
business is profitable, with no debt and has a progressive dividend policy.

 

The Company has been listed on the London Stock Exchange's AIM market since
2005 (AIM: TSTL).

 

For more information about Tristel's product range please visit:
https://tristel.com (https://tristel.com)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAEASXKFSSSEFA